Cochrane Abstracts
Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immune Checkpoint Inhibitors (anti PD‐1 or Anti PD‐L1) Plus Platinum‐etoposide Versus Platinum‐etoposide Alone for First‐line Treatment of Extensive Small Cell Lung Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433240/0/Immune_checkpoint_inhibitors__anti_PD‐1_or_anti_PD‐L1__plus_platinum‐etoposide_versus_platinum‐etoposide_alone_for_first‐line_treatment_of_extensive_small_cell_lung_cancer_New. Accessed 01 October 2023.
Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433240/0/Immune_checkpoint_inhibitors__anti_PD‐1_or_anti_PD‐L1__plus_platinum‐etoposide_versus_platinum‐etoposide_alone_for_first‐line_treatment_of_extensive_small_cell_lung_cancer_New. Accessed October 1, 2023.
Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433240/0/Immune_checkpoint_inhibitors__anti_PD‐1_or_anti_PD‐L1__plus_platinum‐etoposide_versus_platinum‐etoposide_alone_for_first‐line_treatment_of_extensive_small_cell_lung_cancer_New
Immune Checkpoint Inhibitors (anti PD‐1 or Anti PD‐L1) Plus Platinum‐etoposide Versus Platinum‐etoposide Alone for First‐line Treatment of Extensive Small Cell Lung Cancer [Internet]. In: Cochrane Abstracts. [cited 2023 October 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433240/0/Immune_checkpoint_inhibitors__anti_PD‐1_or_anti_PD‐L1__plus_platinum‐etoposide_versus_platinum‐etoposide_alone_for_first‐line_treatment_of_extensive_small_cell_lung_cancer_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) plus platinum‐etoposide versus platinum‐etoposide alone for first‐line treatment of extensive small cell lung cancer
ID - 433240
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433240/0/Immune_checkpoint_inhibitors__anti_PD‐1_or_anti_PD‐L1__plus_platinum‐etoposide_versus_platinum‐etoposide_alone_for_first‐line_treatment_of_extensive_small_cell_lung_cancer_New
DB - Evidence Central
DP - Unbound Medicine
ER -
